Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
BMC Pulmonary Medicine
|
October 31, 2024
Design of a randomised controlled hybrid trial of nintedanib in patients with progressive myositis-associated interstitial lung disease
Rohit Aggarwal, Chester V Oddis, Daniel I Sullivan, et al.
The Journal of Rheumatology
|
April 3, 2018
Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review
Tracy J Doyle, Namrata Dhillon, Rachna Madan, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1982
Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection
W A Krotoski, W E Collins, R S Bray, et al.
The American Journal of Tropical Medicine and Hygiene
|
March 1, 1982
Observations on early and late post-sporozoite tissue stages in primate malaria. II. The hypnozoite of Plasmodium cynomolgi bastianellii from 3 to 105 days after infection, and detection of 36- to 40-hour pre-erythrocytic forms
W A Krotoski, R S Bray, P C Garnham, et al.
ACR Open Rheumatology
|
September 21, 2022
Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis
Chester V Oddis, Howard E Rockette, Lei Zhu, et al.
Arthritis and Rheumatism
|
November 6, 2012
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial
Chester V Oddis, Ann M Reed, Rohit Aggarwal, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
BMC Pulmonary Medicine
|
October 31, 2024
Design of a randomised controlled hybrid trial of nintedanib in patients with progressive myositis-associated interstitial lung disease
Rohit Aggarwal, Chester V Oddis, Daniel I Sullivan, et al.
The Journal of Rheumatology
|
April 3, 2018
Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review
Tracy J Doyle, Namrata Dhillon, Rachna Madan, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1982
Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection
W A Krotoski, W E Collins, R S Bray, et al.
The American Journal of Tropical Medicine and Hygiene
|
March 1, 1982
Observations on early and late post-sporozoite tissue stages in primate malaria. II. The hypnozoite of Plasmodium cynomolgi bastianellii from 3 to 105 days after infection, and detection of 36- to 40-hour pre-erythrocytic forms
W A Krotoski, R S Bray, P C Garnham, et al.
ACR Open Rheumatology
|
September 21, 2022
Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis
Chester V Oddis, Howard E Rockette, Lei Zhu, et al.
Arthritis and Rheumatism
|
November 6, 2012
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial
Chester V Oddis, Ann M Reed, Rohit Aggarwal, et al.
Page
of 3